MetroLatinoUSA

133074 Posts

New Data Show Genentech’s Itovebi Significantly Extended Survival in a Certain Type of HR-positive Advanced Breast Cancer

– The Itovebi (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive, HER2-negative advanced breast cancer, compared with palbociclib and fulvestrant alone – – The PIK3CA mutation is found in approximately 40% of HR-positive advanced breast cancers and is associated with a poor…
Leer más...

Trodelvy® Plus Keytruda® Reduces Risk of Disease Progression or Death by 35% Versus Keytruda and Chemotherapy in First-Line PD-L1+ Metastatic Triple-Negative Breast Cancer

– First Pivotal Phase 3 Trial to Show Superiority of a TROP-2 Antibody-Drug Conjugate, Trodelvy, Plus Keytruda Versus Standard of Care in 1L Metastatic TNBC – – Early Trend in Improvement in Overall Survival Observed –FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced Trodelvy® (sacituzumab govitecan-hziy) plus Keytruda®…
Leer más...

ENHERTU® Reduced the Risk of Death by 30% Versus Ramucirumab Plus Paclitaxel as a Second-Line Therapy in Patients with HER2 Positive Unresectable or Metastatic Gastric Cancer in DESTINY-Gastric04 Phase 3 Trial

Daiichi Sankyo and AstraZeneca’s ENHERTU demonstrated a median overall survival of 14.7 months Results reinforce second-line use of ENHERTU globally in this setting TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Positive results from the DESTINY-Gastric04 phase 3 trial showed ENHERTU® (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in overall…
Leer más...

High School Students Named Best in America at the Council for Economic Education’s 2025 National Economics Challenge

Teams from Maryland, New Hampshire & Georgia Claim Top Honors along with Finalists from Indiana & FloridaATLANTA--(BUSINESS WIRE)--#EconChallenge--High school students who quickly answered tough questions posed to state-championship teams at the Council for Economic Education’s National Economics Challenge (NEC) finals may not change the world today. But they’ll be ready…
Leer más...

ConcertAI Provides Intelligent Automation of ASCO® Guidelines into its Generative and Agentic AI Precision Suite™ and CancerLinQ® SmartLinQ™ Solutions

Powered by CARAai, ASCO® Guideline-concordant care recommendations will be automatically provided to CancerLinQ Network medical oncologists through SmartLinQ, and for biopharma research through Precision Explorer and TrialsCAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal data (MMD) solutions for healthcare and life sciences, today announced…
Leer más...

Natera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients

Donor Quantity Score (DQS) technique is unique to Natera, improving detection of both acute cellular rejection and antibody-mediated rejectionAUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced the launch of Prospera Heart™ with Donor Quantity Score (DQS), further enhancing Prospera’s ability…
Leer más...

Columbus McKinnon Publishes Fourth Annual Corporate Sustainability Report

CHARLOTTE, N.C.--(BUSINESS WIRE)--Columbus McKinnon Corporation (Nasdaq: CMCO) (“Columbus McKinnon” or the “Company), a leading designer and manufacturer of intelligent motion solutions, products and technologies for material handling, today announced the publication of its fourth annual Corporate Sustainability Report. This year, the report provides details on Columbus McKinnon’s performance highlights and…
Leer más...

Comparably Selects Sectigo for 2024 Best Career Growth and Best Leadership Team

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--#certificatemanagement--Sectigo®, the industry’s most innovative provider of comprehensive certificate lifecycle management (CLM), announced today that it has been recognized once again as a best place to work, this time by winning the Comparably Best Career Growth and Best Leadership Team awards. The company was similarly honored in March…
Leer más...